New Turbocharger plant for Holset

New Turbocharger plant for Holset

NEWS/NEWS IN BRIEF Filtration Industry Analyst water equipment companies the necessary impetus to grow at a faster rate. The study, entitled ‘US Mun...

42KB Sizes 2 Downloads 166 Views

NEWS/NEWS IN BRIEF

Filtration Industry Analyst

water equipment companies the necessary impetus to grow at a faster rate. The study, entitled ‘US Municipal Water Equipment Market: Investment Analysis and Growth Opportunities’, reveals that revenue in this market (excluding the pipes and fittings sector) totalled US$4.09 billion in 2004, and projects that it will reach US$5.22 billion by 2011. The municipal water sector accounts for 40% of the total water usage in the USA, says Frost & Sullivan. While water safety and quality concerns are the primary drivers for many investments made at the municipal level, the need to disseminate drinking water efficiently through structured water mains is drawing considerable industry focus. Water, a basic necessity, is turning out to be an investment necessity, says Frost & Sullivan. According to the company, the Environmental Protection Agency estimates that heavy investments will be required in the USA to upgrade or replace the water infrastructure to ensure compliance with the safety standards prescribed by the Safe Drinking Water Act. It says that in order for water equipment manufacturers to take advantage of the increasing opportunities in the municipal water treatment and distribution sector, they must develop new technologies to treat emerging contaminants. While developments in ozone and ultraviolet technologies are expanding the application areas of these technologies, membrane technology may eventually replace conventional filtration equipment, because of its increased reliability and it is financially feasible technology. By upgrading ageing infrastructures with membrane treatment systems, municipalities can achieve cost savings in the long run, says the report.

4

June 2005

DONALDSON TO BUILD SECOND CZECH PLANT Donaldson plans to build its second plant in the Czech Republic, an official said Tuesday. It will invest euro10 million (US$12.3 million) in a new plant in Kadan, 90 kilometers (56 miles) west of Prague, and will employ at least 75 people, the companuy reports. The construction of the plant was scheduled to start this year and production of stationary filters for industrial factories was expected to begin in June 2006, he said. Another Donaldson's plant opened two years ago in Klasterec nad Ohri, 100 kilometers (63 miles) west of Prague, produces filters for diesel engines.

NEW TURBOCHARGER PLANT FOR HOLSET Holset Turbochargers, a division of Cummins Inc headquartered in Huddersfield, West Yorkshire, UK has announced plans to build a mew turbocharger manufacturing facility in Charleston, South Carolina, USA. The $13 million investment in a new 110,000-squarefoot facility will expand Holset's capacity by 200,000 units per year while allowing room for expansion. The plant will focus on heavy duty manufacturing, providing turbochargers for both the US and other global markets. Construction of the new facility is expected to start in May 2005, with the first turbochargers being produced early in the third quarter of 2006. The new plant is 14 miles from Holset’s existing Charleston facility and while it will interact closely with the existing plant, the new one will be a stand-alone facility.

NEWS IN BRIEF • UK supplier of filtration, purification and gas generator products Domnick Hunter has appointed Tegent Technology Ltd as sole agent for its laboratory gas generators in mainland China, Hong Kong and Macau. Domnick Hunter’s laboratory gas generators are used in several industries for applications including liquid chromatography, mass spectroscopy and gas chromatography testing. The range includes ultra high purity nitrogen, hydrogen and zero air generators, carbon dioxide purifiers and laboratory air dryers. Tegent Technology distributes high-end analytical laboratory instruments, and has been engaged in this line of business for more than a decade. • Weir Techna, represented by Weir Entropie and Weir Techna Middle East, has been selected by Public Electricity Corporation (PEC), the state-owned Power utility company of Yemen, to supply three water desalination units, each rated at 1200 m3/day. The contract is worth in excess of euro4 million. Weir Entropie will supply the desalination equipment while Weir Techna Middle East will be in charge of the auxiliary equipment and site works, including construction. The turnkey plant is expected to be completed in 20 months. • Whitehouse Scientific of Waverton, UK, says that the application of increasingly stringent quality assurance standards for sieve analysis techniques, specified by international standards organizations, is fuelling a growth in demand for its sieve calibration standards. The high demand from

Spanish and Latin American countries, in particular, has led to the appointment of a distributor for the company’s sieve calibration products in these market places. CISA Cedacería Industrial, based in Barcelona, Spain, is to distribute the company's sieve standards – with full instructions and test certificates provided in Spanish. • Following a request by the independent examiner in FiberMark Inc’s Chapter 11 case, the US Bankruptcy Court, District of Vermont, USA, has extended the examination period until 30 June 2005, established a report filing deadline of 6 July 2005 and scheduled a report review hearing for 12 July 2005 (See ‘FiberMark withdraws reorganization plan’, Filtration + Separation, May 2005). The company intends to file a new plan of reorganization as soon as possible. The deadline for any plan of reorganization filing remains 8 August 2005. • In the USA, Pure Bioscience has completed the sale of its water treatment division to Innovative Medical Services Llc. At closing of the deal, the company received US$1.95 million in cash. It will also receive two post-closing payments – one for an amount of US$225 000, within 90 days, and the remaining US$200 000 within 13 months. Pure Bioscience says that it will use the proceeds of the sale to retire substantially all debt, and to capitalize the continuing commercialization of its current and future bioscience products, including those for its most recent licensee, Ciba Specialty Chemicals.